It's a common clinical conundrum - abnormal liver function tests.
Recognising common and less common causes of abnormal LFTs.
In this webcast on 31 March, Dr Emily Nash will discuss a framework to interpret abnormal LFTS and suggest diagnostic algorithms to help clinicians determine the most appropriate next step in management be it treatment, further investigation or referral. In addition, she will use primary and secondary case studies to demonstrate the common and less common causes of abnormal LFTs.
How do the CPD options work?
- Attend the webcast and earn 2 hrs CPD in the Educational Activities category by attending the webcast lecture and completing the evaluation (RACGP & ACRRM approved)
- Complete the optional post-webcast quiz and earn 0.5 hrs CPD in the Reviewing Performance category (RACGP & ACRRM approved)
- Complete the optional Patient Case Review and earn a further 0.5 hrs CPD in the Reviewing Performance category (RACGP & ACRRM approved)
- Undertake the optional Micro Audit and gain 1 hrs CPD in the Measuring Outcomes category (RACGP & ACRRM approved)
Other professions can self-claim up to 4 hrs CPD.
Attendees will receive Certificate of Attendance about four weeks post-webcast.
Don’t miss out, REGISTER NOW.
Topics include:
Vitiligo – Early Detection and Early Treatment
Dr Adrian Mar
Dermatologist; Head, Department of Dermatology, Monash Health; Adjunct Associate Professor, Department of Medicine, Monash University; Visiting Consultant, Vitiligo Clinic, Skin Health Institute
Recognising vitiligo early is crucial if patients are going to have a chance to prevent progression and promote repigmentation of this autoimmune skin disorder. In this talk, Associate Professor Adrian Mar will discuss the key early diagnostic features of vitiligo, a condition that can have serious psychological, social, and cultural impacts, especially in darker skin types. He will also present current management options including topical immunosuppressants, phototherapy, and, in stable cases, surgery.
Abnormal Liver Function Test
Dr Emily Nash
Gastroenterologist and Hepatologist; Chris O’Brien Lifehouse; Staff Specialist, Royal Prince Alfred Hospital; Clinical Associate Lecturer, University of Sydney
It’s a common clinical conundrum – abnormal liver function tests. In this presentation, Dr Emily Nash will discuss a framework to interpret abnormal LFTS and suggest diagnostic algorithms to help clinicians determine the most appropriate next step in management be it treatment, further investigation or referral. In addition, she will use primary and secondary case studies to demonstrate the common and less common causes of abnormal LFTs.
Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow
Prof Kelly-Anne Phillips
Consultant Medical Oncologist, Peter MacCallum Cancer Centre; NHMRC Leadership Fellow, National Health and Medical Research Council; Honorary Professorial Fellow, The University of Melbourne
High mammographic breast density is an important risk factor for breast cancer and is now routinely reported by BreastScreen in several Australian states.
In this talk, Professor Kelly-Anne Phillips will explain what breast density means for individual risk and how results should be interpreted and managed in the primary care setting. She will also discuss the role of validated tools such as iPrevent, which incorporate breast density and other risk factors, in helping both clinicians and patients understand a woman’s personal risk and enable the development of a tailored screening and prevention plan that may or may not include referral for genetic testing.
Recurrent Nasal Polyps Management – When to Refer
Prof Richard Harvey
Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon, Macquarie University, St Vincent’s Hospitals, Sydney; Program Head, Rhinology & Skull Base Surgery, Applied Medical Research Center, UNSW; Professor, UNSW, Macquarie University
Nasal polyps are an endpoint of an inflammatory process rather than a standalone disease, and as such need a broader treatment approach than simply removal.
In this talk, Professor Richard Harvey gives an overview of our current understanding of the pathophysiology of nasal polyps, how we can best determine the cause of nasal polyps in primary care patients and instigate appropriate treatment for this condition that is both common and miserable.
Date:
Tuesday 31 March 2026
Time:
7pm – 9pm AEDT (NSW, VIC, TAS, ACT)
6pm – 8pm AEST (QLD)
6:30pm – 8:30pm ACDT (SA)
5:30pm – 7:30pm ACST (NT)
4pm – 6pm AWST (WA)
